BackSurmodics Overview

Surmodics Total Assets

Track Surmodics's total assets ($170M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$169.82M
↓ 4.28% YoYΔ $-7.59M vs prior year quarter

Peer average

Loading

Surmodics Total Assets History

Loading

Surmodics vs. peers: Total Assets Comparison

Loading

Surmodics Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Surmodics (SRDX) FAQ

Surmodics (SRDX) currently reports a total assets of $170M as of June 2025. That compares with $180M in the prior-year period — down 4.3% year over year. Use the charts on this page to explore Surmodics's total assets history and peer comparisons.

Surmodics's total assets decreased from $180M to $170M — a 4.3% year-over-year decrease (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Surmodics reported $170M in total assets as of June 2025. That compares with $180M in the prior-year period — down 4.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $170M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Surmodics, and consider following SRDX for alerts when major investors trade the stock.

Surmodics is classified in the Healthcare sector. On total assets, it currently shows $170M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SRDX with unrelated industries.